CX Daily: Chinese Pharma Turns to Global Deals to Cure Capital Crunch
Biotech / Cover story: Chinese pharma turns to global deals to cure capital crunch After enduring the chill of a prolonged capital winter, China’s...
386 Views
Cutting-Edge Drugmaker Biokin Taps Hong Kong Market to Fund Foray Aboard
Chinese innovative drugmaker Sichuan Biokin Pharmaceutical Co. Ltd. has filed with the Hong Kong Stock Exchange for an initial public offering...
411 Views